Expanding Comparative Effectiveness Research (CER) Capability Through Complex Patient Relationship Management

NCT ID: NCT01391585

Last Updated: 2014-02-11

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 135 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2011-06-30
• Study Completion Date: 2012-08-31

Brief Summary

The investigators are testing whether patients with diabetes can communicate with our health care system through text messaging. The investigators will look at how often they respond to prompts for blood pressures, blood sugars, and step counts. The investigators will also see if they come in for lab tests when prompted by text message. Also, for patients overdue for medication refills, the investigators will ask them why they have not yet called for the refill.

Detailed Description

Patients will be sent text messages through a software interface, the Patient Relationship Manager (PRM). A registered nurse will also use PRM to receive incoming responses. Tasks will be created for her to outreach to patients who have out of range text responses or poor response rates. This intervention if a feasibility study to see if patients can communicate with the investigator's health care system and potentially utilize PRM to better manage their diabetes.

Conditions

Diabetes; Hyperlipidemia

Study Design

• Allocation Method: NON_RANDOMIZED
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: HEALTH_SERVICES_RESEARCH
• Blinding Strategy: NONE

Study Groups

text message recipients

Patients will be recruited to receive text messages

Group Type: EXPERIMENTAL

Text Message prompts

Intervention Type: OTHER

In this single armed intervention, patients will receive text message prompts

Interventions

Text Message prompts

In this single armed intervention, patients will receive text message prompts

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• age 18-75 years
• diabetes
• own a cell phone
• 2 primary care visits in last year
• English or Spanish speaking

Exclusion Criteria

• End-stage disease with estimate of less than 6 months to live

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Agency for Healthcare Research and Quality (AHRQ)

FED

Sponsor Role: collaborator

Denver Health and Hospital Authority

OTHER

Sponsor Role: lead

Responsible Party

Henry Fischer

MD

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

henry h fischer, MD

Role: PRINCIPAL_INVESTIGATOR

Denver Health

Locations

Denver Health

Denver, Colorado, United States

Countries

United States

Other Identifiers

R24HS019453-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

R24HS019453-01PRM

Identifier Type: -

Identifier Source: org_study_id